These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

571 related articles for article (PubMed ID: 10485912)

  • 21. Ischaemia-induced retinal neovascularisation and diabetic retinopathy in mice with conditional knockout of hypoxia-inducible factor-1 in retinal Müller cells.
    Lin M; Chen Y; Jin J; Hu Y; Zhou KK; Zhu M; Le YZ; Ge J; Johnson RS; Ma JX
    Diabetologia; 2011 Jun; 54(6):1554-66. PubMed ID: 21360191
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Curcumin Attenuates Retinal Vascular Leakage by Inhibiting Calcium/Calmodulin-Dependent Protein Kinase II Activity in Streptozotocin-Induced Diabetes.
    Li J; Wang P; Ying J; Chen Z; Yu S
    Cell Physiol Biochem; 2016; 39(3):1196-208. PubMed ID: 27595397
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effective and selective prevention of retinal leukostasis in streptozotocin-induced diabetic rats using gliclazide.
    Kinoshita N; Kakehashi A; Inoda S; Itou Y; Kuroki M; Yasu T; Kawakami M; Kanazawa Y
    Diabetologia; 2002 May; 45(5):735-9. PubMed ID: 12107755
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of NADPH oxidase in retinal vascular inflammation.
    Al-Shabrawey M; Rojas M; Sanders T; Behzadian A; El-Remessy A; Bartoli M; Parpia AK; Liou G; Caldwell RB
    Invest Ophthalmol Vis Sci; 2008 Jul; 49(7):3239-44. PubMed ID: 18378574
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TNFalpha is required for late BRB breakdown in diabetic retinopathy, and its inhibition prevents leukostasis and protects vessels and neurons from apoptosis.
    Huang H; Gandhi JK; Zhong X; Wei Y; Gong J; Duh EJ; Vinores SA
    Invest Ophthalmol Vis Sci; 2011 Mar; 52(3):1336-44. PubMed ID: 21212173
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peroxynitrite decomposition catalyst, FP15, and poly(ADP-ribose) polymerase inhibitor, PJ34, inhibit leukocyte entrapment in the retinal microcirculation of diabetic rats.
    Sugawara R; Hikichi T; Kitaya N; Mori F; Nagaoka T; Yoshida A; Szabo C
    Curr Eye Res; 2004 Jul; 29(1):11-6. PubMed ID: 15370362
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phosphomannopentaose sulfate (PI-88) inhibits retinal leukostasis in diabetic rat.
    Ma P; Luo Y; Zhu X; Ma H; Hu J; Tang S
    Biochem Biophys Res Commun; 2009 Mar; 380(2):402-6. PubMed ID: 19250642
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Retinopathy in a novel model of metabolic syndrome and type 2 diabetes: new insight on the inflammatory paradigm.
    Noda K; Nakao S; Zandi S; Sun D; Hayes KC; Hafezi-Moghadam A
    FASEB J; 2014 May; 28(5):2038-46. PubMed ID: 24571922
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic potential of a monoclonal antibody blocking the Wnt pathway in diabetic retinopathy.
    Lee K; Hu Y; Ding L; Chen Y; Takahashi Y; Mott R; Ma JX
    Diabetes; 2012 Nov; 61(11):2948-57. PubMed ID: 22891217
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of endothelin dual receptor antagonist on VEGF levels in streptozotocin-induced diabetic rat retina.
    Masuzawa K; Jesmin S; Maeda S; Zaedi S; Shimojo N; Miyauchi T; Goto K
    Exp Biol Med (Maywood); 2006 Jun; 231(6):1090-4. PubMed ID: 16741055
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fenofibrate ameliorates diabetic retinopathy by modulating Nrf2 signaling and NLRP3 inflammasome activation.
    Liu Q; Zhang F; Zhang X; Cheng R; Ma JX; Yi J; Li J
    Mol Cell Biochem; 2018 Aug; 445(1-2):105-115. PubMed ID: 29264825
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of antioxidant N-acetylcysteine on diabetic retinopathy and expression of VEGF and ICAM-1 from retinal blood vessels of diabetic rats.
    Zhu Y; Zhang XL; Zhu BF; Ding YN
    Mol Biol Rep; 2012 Apr; 39(4):3727-35. PubMed ID: 21952821
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PKC-beta inhibitor (LY333531) attenuates leukocyte entrapment in retinal microcirculation of diabetic rats.
    Nonaka A; Kiryu J; Tsujikawa A; Yamashiro K; Miyamoto K; Nishiwaki H; Honda Y; Ogura Y
    Invest Ophthalmol Vis Sci; 2000 Aug; 41(9):2702-6. PubMed ID: 10937586
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term global retinal microvascular changes in a transgenic vascular endothelial growth factor mouse model.
    Shen WY; Lai CM; Graham CE; Binz N; Lai YK; Eade J; Guidolin D; Ribatti D; Dunlop SA; Rakoczy PE
    Diabetologia; 2006 Jul; 49(7):1690-701. PubMed ID: 16752188
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of dual PPAR-α/γ agonist saroglitazar on diabetic retinopathy and oxygen-induced retinopathy.
    Joharapurkar A; Patel V; Kshirsagar S; Patel MS; Savsani H; Jain M
    Eur J Pharmacol; 2021 May; 899():174032. PubMed ID: 33753107
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metanx and early stages of diabetic retinopathy.
    Liu H; Tang J; Lee CA; Kern TS
    Invest Ophthalmol Vis Sci; 2015 Jan; 56(1):647-53. PubMed ID: 25574044
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting of 12/15-Lipoxygenase in retinal endothelial cells, but not in monocytes/macrophages, attenuates high glucose-induced retinal leukostasis.
    Ibrahim AS; Saleh H; El-Shafey M; Hussein KA; El-Masry K; Baban B; Sheibani N; Wang MH; Tawfik A; Al-Shabrawey M
    Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Jun; 1862(6):636-645. PubMed ID: 28351645
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FT011, a Novel Cardiorenal Protective Drug, Reduces Inflammation, Gliosis and Vascular Injury in Rats with Diabetic Retinopathy.
    Deliyanti D; Zhang Y; Khong F; Berka DR; Stapleton DI; Kelly DJ; Wilkinson-Berka JL
    PLoS One; 2015; 10(7):e0134392. PubMed ID: 26222724
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Suppression of diabetic retinopathy with angiopoietin-1.
    Joussen AM; Poulaki V; Tsujikawa A; Qin W; Qaum T; Xu Q; Moromizato Y; Bursell SE; Wiegand SJ; Rudge J; Ioffe E; Yancopoulos GD; Adamis AP
    Am J Pathol; 2002 May; 160(5):1683-93. PubMed ID: 12000720
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Beneficial effects of a novel RAGE inhibitor on early diabetic retinopathy and tactile allodynia.
    Li G; Tang J; Du Y; Lee CA; Kern TS
    Mol Vis; 2011; 17():3156-65. PubMed ID: 22171162
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.